Free Trial

Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 5.6% - Here's Why

Kestra Medical Technologies logo with Manufacturing background

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) traded down 5.6% during trading on Monday . The stock traded as low as $21.01 and last traded at $21.27. 68,622 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 190,155 shares. The stock had previously closed at $22.52.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on KMTS shares. Wolfe Research began coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set an "outperform" rating and a $29.00 price target on the stock. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $28.00 price objective for the company. The Goldman Sachs Group reduced their target price on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a report on Wednesday, April 16th. Piper Sandler initiated coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an "overweight" rating and a $27.00 price target on the stock. Finally, Bank of America started coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They set a "buy" rating and a $30.00 price target for the company. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $27.50.

Check Out Our Latest Research Report on KMTS

Kestra Medical Technologies Stock Up 0.8%

The company has a 50-day moving average of $23.34.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last released its earnings results on Monday, April 14th. The company reported ($1.25) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same quarter last year, the business earned ($1.18) EPS.

Institutional Trading of Kestra Medical Technologies

Several large investors have recently made changes to their positions in KMTS. Jane Street Group LLC bought a new stake in Kestra Medical Technologies during the first quarter valued at about $756,000. Woodline Partners LP acquired a new position in shares of Kestra Medical Technologies in the 1st quarter valued at $2,510,000. Yu Fan bought a new position in shares of Kestra Medical Technologies during the 1st quarter worth about $56,880,000. Zimmer Partners LP bought a new position in shares of Kestra Medical Technologies during the 1st quarter worth approximately $374,000. Finally, Millennium Management LLC bought a new stake in Kestra Medical Technologies during the first quarter worth about $11,036,000.

Kestra Medical Technologies Company Profile

(Get Free Report)

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

Read More

Should You Invest $1,000 in Kestra Medical Technologies Right Now?

Before you consider Kestra Medical Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.

While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines